| Neutrophil extracellular traps in COVID-19 Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo, JA Madison, C Blair, ... JCI insight 5 (11), 2020 | 1510 | 2020 |
| Association between mRNA vaccination and COVID-19 hospitalization and disease severity MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Jama 326 (20), 2043-2054, 2021 | 600 | 2021 |
| Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... bmj 376, 2022 | 531 | 2022 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 467 | 2021 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 252 | 2021 |
| Neutrophil calprotectin identifies severe pulmonary disease in COVID-19 H Shi, Y Zuo, S Yalavarthi, K Gockman, M Zuo, JA Madison, C Blair, ... Journal of Leucocyte Biology 109 (1), 67-72, 2021 | 138 | 2021 |
| Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts AL Valesano, KE Rumfelt, DE Dimcheff, CN Blair, WJ Fitzsimmons, ... PLoS pathogens 17 (4), e1009499, 2021 | 101 | 2021 |
| Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 91 | 2022 |
| Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... Clinical infectious diseases 74 (9), 1515-1524, 2022 | 84 | 2022 |
| Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study K Adams, JP Rhoads, D Surie, M Gaglani, AA Ginde, T McNeal, HK Talbot, ... Bmj 379, 2022 | 69 | 2022 |
| SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients DE Dimcheff, AL Valesano, KE Rumfelt, WJ Fitzsimmons, C Blair, ... The Journal of Infectious Diseases, 2021 | 47 | 2021 |
| High prevalence of extended-spectrum beta-lactamase CTX-M–producing Escherichia coli in small-scale poultry farming in rural Ecuador HD Hedman, JNS Eisenberg, KA Vasco, CN Blair, G Trueba, VJ Berrocal, ... The American journal of tropical medicine and hygiene 100 (2), 374, 2019 | 31 | 2019 |
| SARS-CoV-2 genomic surveillance reveals little spread from a large university campus to the surrounding community AL Valesano, WJ Fitzsimmons, CN Blair, RJ Woods, J Gilbert, D Rudnik, ... Open Forum Infectious Diseases 8 (11), ofab518, 2021 | 22 | 2021 |
| Effectiveness of mRNA vaccines against COVID-19 hospitalization by age and chronic medical conditions burden among immunocompetent US adults, March-August 2021 NM Lewis, EA Naioti, WH Self, AA Ginde, DJ Douin, H Keipp Talbot, ... The Journal of infectious diseases 225 (10), 1694-1700, 2022 | 19 | 2022 |
| Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness M Stephenson, SM Olson, WH Self, AA Ginde, NM Mohr, M Gaglani, ... Influenza and other respiratory viruses 16 (6), 1101-1111, 2022 | 16 | 2022 |
| Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States MW Tenforde, WH Self, Y Zhu, EA Naioti, M Gaglani, AA Ginde, K Jensen, ... Clinical infectious diseases 76 (3), ciac381, 2023 | 7 | 2023 |
| Effectiveness of the Ad26. COV2. S (Johnson & Johnson) COVID-19 vaccine for preventing COVID-19 hospitalizations and progression to high disease severity in the United States NM Lewis, WH Self, M Gaglani, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 2 | 2022 |
| Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021 IVY Network Collaborators Journal of Infectious Diseases 225 (10), 1694-1700, 2022 | | 2022 |
